Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Strategies for safe living following solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Avery RK, Michaels MG; AST Infectious Diseases Community of Practice.

Clin Transplant. 2019 Mar 7:e13519. doi: 10.1111/ctr.13519. [Epub ahead of print]

PMID:
30844096
2.

Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.

Papanicolaou GA, Silveira FP, Langston AA, Pereira MR, Avery RK, Uknis M, Wijatyk A, Wu J, Boeckh M, Marty FM, Villano S.

Clin Infect Dis. 2019 Apr 8;68(8):1255-1264. doi: 10.1093/cid/ciy706.

3.

Cutaneous Complications in Recipients of Lung Transplants: A Pictorial Review.

Tejwani V, Deshwal H, Ho B, Loss MJ, Avery RK, Mehta AC.

Chest. 2019 Jan;155(1):178-193. doi: 10.1016/j.chest.2018.08.1060. Epub 2018 Sep 7. Review.

PMID:
30201407
4.

Low pretransplant IgA level is associated with early post-lung transplant seromucous infection.

Murthy SC, Avery RK, Budev M, Gupta S, Pettersson GB, Nowicki ER, Mehta A, Chapman JT, Rajeswaran J, Blackstone EH.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):882-891.e8. doi: 10.1016/j.jtcvs.2018.03.165. Epub 2018 Apr 13.

PMID:
29779634
5.

Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.

Avery RK, Silveira FP, Benedict K, Cleveland AA, Kauffman CA, Schuster MG, Dubberke ER, Husain S, Paterson DL, Chiller T, Pappas P.

Transpl Infect Dis. 2018 Jun;20(3):e12877. doi: 10.1111/tid.12877. Epub 2018 Mar 30.

6.

Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.

Dubberke ER, Reske KA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, Schuster MG, Kauffman CA, Avery RK, Pappas PG, Chiller TM.

Transpl Infect Dis. 2018 Apr;20(2):e12855. doi: 10.1111/tid.12855. Epub 2018 Mar 6.

7.

A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Chong PP, Avery RK.

Clin Ther. 2017 Aug;39(8):1581-1598. doi: 10.1016/j.clinthera.2017.07.005. Epub 2017 Jul 24. Review.

PMID:
28751095
8.

Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study.

Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, Paterson DL, Silveira FP, Chiller TM, Benedict K, Murphy K, Pappas PG.

Open Forum Infect Dis. 2017 Mar 22;4(2):ofx050. doi: 10.1093/ofid/ofx050. eCollection 2017 Spring.

9.

Endovascular Embolization by Transcatheter Delivery of Particles: Past, Present, and Future.

Sheth RA, Sabir S, Krishnamurthy S, Avery RK, Zhang YS, Khademhosseini A, Oklu R.

J Funct Biomater. 2017 Apr 3;8(2). pii: E12. doi: 10.3390/jfb8020012. Review.

10.

Disseminated cat-scratch disease presenting as nausea, diarrhea, and weight loss without fever in a heart transplant recipient.

Antar AAR, Goyal A, Murphy K, Schimmel M, Gilotra NA, Martin I, Crane GM, Sciortino C, Avery RK, Houston BA.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12678. Epub 2017 May 26.

PMID:
28199763
11.

Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under-recognized syndrome.

Avery RK, Lonze BE, Kraus ES, Marr KA, Montgomery RA.

Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12674. Epub 2017 Mar 16.

PMID:
28176463
12.

Classical Challenges in the Physical Chemistry of Polymer Networks and the Design of New Materials.

Wang R, Sing MK, Avery RK, Souza BS, Kim M, Olsen BD.

Acc Chem Res. 2016 Dec 20;49(12):2786-2795. Epub 2016 Nov 23.

PMID:
27993006
13.

An injectable shear-thinning biomaterial for endovascular embolization.

Avery RK, Albadawi H, Akbari M, Zhang YS, Duggan MJ, Sahani DV, Olsen BD, Khademhosseini A, Oklu R.

Sci Transl Med. 2016 Nov 16;8(365):365ra156.

PMID:
27856795
14.

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.

Avery RK, Arav-Boger R, Marr KA, Kraus E, Shoham S, Lees L, Trollinger B, Shah P, Ambinder R, Neofytos D, Ostrander D, Forman M, Valsamakis A.

Transplantation. 2016 Oct;100(10):e74-80. doi: 10.1097/TP.0000000000001418.

15.

Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.

Kucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi BJ, McAdams-DeMarco M, Grams ME, Segev DL.

Am J Transplant. 2016 Aug;16(8):2368-76. doi: 10.1111/ajt.13840. Epub 2016 May 25.

16.

Toughening of Thermoresponsive Arrested Networks of Elastin-Like Polypeptides To Engineer Cytocompatible Tissue Scaffolds.

Glassman MJ, Avery RK, Khademhosseini A, Olsen BD.

Biomacromolecules. 2016 Feb 8;17(2):415-26. doi: 10.1021/acs.biomac.5b01210. Epub 2016 Jan 20.

17.

Thermoresponsive and Mechanical Properties of Poly(L-proline) Gels.

Gkikas M, Avery RK, Olsen BD.

Biomacromolecules. 2016 Feb 8;17(2):399-406. doi: 10.1021/acs.biomac.5b01168. Epub 2016 Jan 6.

18.

Invasive aspergillosis before HCT: safe to proceed?

Avery RK.

Bone Marrow Transplant. 2016 Mar;51(3):346-7. doi: 10.1038/bmt.2015.302. Epub 2015 Dec 14. No abstract available.

PMID:
26657833
19.

A Highly Elastic and Rapidly Crosslinkable Elastin-Like Polypeptide-Based Hydrogel for Biomedical Applications.

Zhang YN, Avery RK, Vallmajo-Martin Q, Assmann A, Vegh A, Memic A, Olsen BD, Annabi N, Khademhosseini A.

Adv Funct Mater. 2015 Aug 12;25(30):4814-4826. Epub 2015 Jul 1.

20.

Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases.

Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, Hamoud KA, Burdette SD, Freifeld AG, McKinsey DS, Money ME, Myint T, Andes DR, Hoey CA, Kaul DA, Dickter JK, Liebers DE, Miller RA, Muth WE, Prakash V, Steiner FT, Walker RC, Hage CA.

Clin Infect Dis. 2015 Aug 1;61(3):409-17. doi: 10.1093/cid/civ299. Epub 2015 Apr 13.

21.

Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.

Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Mone T, Orlowski JP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, Kumar D.

Am J Transplant. 2015 May;15(5):1162-72. doi: 10.1111/ajt.13187. Epub 2015 Feb 23.

22.

Shear-thinning nanocomposite hydrogels for the treatment of hemorrhage.

Gaharwar AK, Avery RK, Assmann A, Paul A, McKinley GH, Khademhosseini A, Olsen BD.

ACS Nano. 2014 Oct 28;8(10):9833-42. doi: 10.1021/nn503719n. Epub 2014 Oct 8.

23.

Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Kovacs CS Jr, Koval CE, van Duin D, de Morais AG, Gonzalez BE, Avery RK, Mawhorter SD, Brizendine KD, Cober ED, Miranda C, Shrestha RK, Teixeira L, Mossad SB.

World J Transplant. 2014 Jun 24;4(2):43-56. doi: 10.5500/wjt.v4.i2.43. Review.

24.

Characterization, prophylaxis, and treatment of infectious complications in craniomaxillofacial and upper extremity allotransplantation: a multicenter perspective.

Broyles JM, Alrakan M, Ensor CR, Khalifian S, Kotton CN, Avery RK, Brandacher G, Lee WP, Gordon CR.

Plast Reconstr Surg. 2014 Apr;133(4):543e-51e. doi: 10.1097/PRS.0000000000000015. Review.

PMID:
24675206
25.

KIR and HLA interactions are associated with control of primary CMV infection in solid organ transplant recipients.

van Duin D, Avery RK, Hemachandra S, Yen-Lieberman B, Zhang A, Jain A, Butler RS, Barnard J, Schold JD, Fung J, Askar M.

Am J Transplant. 2014 Jan;14(1):156-62. doi: 10.1111/ajt.12532.

26.

Update on infections in composite tissue allotransplantation.

Avery RK.

Curr Opin Organ Transplant. 2013 Dec;18(6):659-64. doi: 10.1097/MOT.0000000000000023. Review.

PMID:
24220048
27.

Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients.

Durand CM, Marr KA, Arnold CA, Tang L, Durand DJ, Avery RK, Valsamakis A, Neofytos D.

Clin Infect Dis. 2013 Dec;57(11):1550-9. doi: 10.1093/cid/cit521. Epub 2013 Aug 15.

28.

Hypogammaglobulinemia: time to reevaluate?

Avery RK, Blumberg EA.

Am J Transplant. 2013 Oct;13(10):2517-8. doi: 10.1111/ajt.12403. Epub 2013 Aug 7. No abstract available.

29.

Comparative study of bronchial artery revascularization in lung transplantation.

Pettersson GB, Karam K, Thuita L, Johnston DR, McCurry KR, Kapadia SR, Budev MM, Avery RK, Mason DP, Murthy SC, Blackstone EH.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):894-900.e3. doi: 10.1016/j.jtcvs.2013.04.030. Epub 2013 Jun 29.

30.

Human metapneumovirus infection: worthy of recognition.

Avery RK.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1138-9. doi: 10.1016/j.bbmt.2013.06.009. Epub 2013 Jun 18. No abstract available.

31.

Mycobacterium llatzerense lung infection in a liver transplant recipient: case report and review of the literature.

Teixeira L, Avery RK, Iseman M, Arrossi AV, Harrington S, Stephens K, Winans CG.

Am J Transplant. 2013 Aug;13(8):2198-200. doi: 10.1111/ajt.12318. Epub 2013 Jun 13. Review.

32.

Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.

Cuellar-Rodriguez J, Stephany B, Poggio E, Mossad SB, Goldfarb D, Lard M, Askar M, Fatica R, Srinivas T, Braun W, Shoskes D, Flechner S, Schmitt SK, Shrestha R, Avery RK.

Clin Transplant. 2013 May-Jun;27(3):E230-6. doi: 10.1111/ctr.12110. Epub 2013 Apr 3.

PMID:
23551281
33.

Strategies for safe living after solid organ transplantation.

Avery RK, Michaels MG; AST Infectious Diseases Community of Practice.

Am J Transplant. 2013 Mar;13 Suppl 4:304-10. doi: 10.1111/ajt.12121. No abstract available.

34.

Influenza vaccines in the setting of solid-organ transplantation: are they safe?

Avery RK.

Curr Opin Infect Dis. 2012 Aug;25(4):464-8. doi: 10.1097/QCO.0b013e328355a79b. Review.

PMID:
22710319
35.

Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients.

Malinis MF, Mawhorter SD, Jain A, Shrestha NK, Avery RK, van Duin D.

Transplantation. 2012 May 27;93(10):1045-50. doi: 10.1097/TP.0b013e31824bf219.

PMID:
22357175
36.

Antifungal prophylaxis in lung transplantation.

Avery RK.

Semin Respir Crit Care Med. 2011 Dec;32(6):717-26. doi: 10.1055/s-0031-1295719. Epub 2011 Dec 13. Review.

PMID:
22167399
37.

What is the true significance of donor-related cytomegalovirus transmission in the setting of facial composite tissue allotransplantation?

Gordon CR, Abouhassan W, Avery RK.

Transplant Proc. 2011 Nov;43(9):3516-20. doi: 10.1016/j.transproceed.2011.08.043. Review.

PMID:
22099832
38.

Influenza vaccination in the organ transplant recipient: review and summary recommendations.

Kumar D, Blumberg EA, Danziger-Isakov L, Kotton CN, Halasa NB, Ison MG, Avery RK, Green M, Allen UD, Edwards KM, Miller G, Michaels MG; AST Infectious Diseases Community of Practice.

Am J Transplant. 2011 Oct;11(10):2020-30. doi: 10.1111/j.1600-6143.2011.03753.x. Review.

39.

Predictors of acute rejection after lung transplantation.

Mangi AA, Mason DP, Nowicki ER, Batizy LH, Murthy SC, Pidwell DJ, Avery RK, McCurry KR, Pettersson GB, Blackstone EH.

Ann Thorac Surg. 2011 Jun;91(6):1754-62. doi: 10.1016/j.athoracsur.2011.01.076. Epub 2011 May 4.

PMID:
21536252
40.

Cytomegalovirus and other infectious issues related to face transplantation: specific considerations, lessons learned, and future recommendations.

Gordon CR, Avery RK, Abouhassan W, Siemionow M.

Plast Reconstr Surg. 2011 Apr;127(4):1515-23. doi: 10.1097/PRS.0b013e318208d03c.

PMID:
21460660
41.

Extreme alkaline phosphatase elevation associated with tigecycline.

Bonilla MF, Avery RK, Rehm SJ, Neuner EA, Isada CM, van Duin D.

J Antimicrob Chemother. 2011 Apr;66(4):952-3. doi: 10.1093/jac/dkr015. Epub 2011 Feb 2. No abstract available.

PMID:
21393193
42.

Lung transplantation in a recipient with novel 2009 H1N1 influenza: lessons learned.

Mason DP, Murthy SC, Yun JJ, Machuzak M, Shrestha R, Avery RK, McCurry KR, Budev MM, Pettersson GB.

Thorac Cardiovasc Surg. 2011 Mar;59(2):126-7. doi: 10.1055/s-0030-1250240. Epub 2011 Mar 7.

PMID:
21384312
43.

Low-dose valganciclovir for cytomegalovirus prophylaxis in organ transplantation: is less really more?

Avery RK.

Clin Infect Dis. 2011 Feb 1;52(3):322-4. doi: 10.1093/cid/ciq145. Epub 2010 Dec 28. No abstract available.

PMID:
21190935
44.

Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.

Avery RK, Mossad SB, Poggio E, Lard M, Budev M, Bolwell B, Waldman WJ, Braun W, Mawhorter SD, Fatica R, Krishnamurthi V, Young JB, Shrestha R, Stephany B, Lurain N, Yen-Lieberman B.

Transplantation. 2010 Aug 27;90(4):419-26. doi: 10.1097/TP.0b013e3181e94106.

PMID:
20683281
45.

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.

Avery RK, Marty FM, Strasfeld L, Lee I, Arrieta A, Chou S, Tatarowicz W, Villano S.

Transpl Infect Dis. 2010 Dec;12(6):489-96. doi: 10.1111/j.1399-3062.2010.00550.x.

PMID:
20682012
46.

Immunosuppressive agents and CMV risk in the VICTOR study.

Avery RK, Kaplan B.

Am J Transplant. 2010 Aug;10(8):1727-8. doi: 10.1111/j.1600-6143.2010.03194.x. No abstract available.

47.

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study.

Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharka VR, Alavi G, Kalpoe JS, Shoham S, Reid GE, Humar A; American Society of Transplantation H1N1 Collaborative Study Group.

Lancet Infect Dis. 2010 Aug;10(8):521-6. doi: 10.1016/S1473-3099(10)70133-X. Epub 2010 Jul 9.

48.

Infectious disease following kidney transplant: core curriculum 2010.

Avery RK.

Am J Kidney Dis. 2010 Apr;55(4):755-71. doi: 10.1053/j.ajkd.2009.12.029. Review. No abstract available.

PMID:
20338466
49.

Screening of donor and recipient prior to solid organ transplantation.

Fischer SA, Avery RK; AST Infectious Disease Community of Practice.

Am J Transplant. 2009 Dec;9 Suppl 4:S7-18. doi: 10.1111/j.1600-6143.2009.02888.x. No abstract available.

50.

Strategies for safe living following solid organ transplantation.

Avery RK, Michaels MG; AST Infectious Diseases Community of Practice.

Am J Transplant. 2009 Dec;9 Suppl 4:S252-7. doi: 10.1111/j.1600-6143.2009.02916.x. No abstract available.

Supplemental Content

Loading ...
Support Center